ABLYNX
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 projects in the pipeline and five Nanobodies in clinical development.
ABLYNX
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2001-01-01
Address:
Zwijnaarde, Oost-Vlaanderen, Belgium
Country:
Belgium
Website Url:
http://www.ablynx.com
Total Employee:
251+
Status:
Active
Contact:
(092) 620-000_
Email Addresses:
[email protected]
Total Funding:
498.78 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Google Maps API Mimecast Adobe Enterprise Cloud Verisign Seal
Similar Organizations
Acacia Pharma
Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.
Almac Group
Almac is a financially secure, privately owned organisation with over 4,500 employees located within the US, Europe and Asia.
Ark Biosciences
Ark Biosciences is a biopharmaceutical company that is dedicated to the discovery and development
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Palau Pharma S.A.
PALAU PHARMA is a newly created biopharmaceutical company, whose mission is the discovery and development of drug candidates.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Pomona Ricera
This company is a private discovery-stage biotech company engaged in the design, development and production.
Proacta Therapeutics
Proacta Therapeutics is a biopharmaceutical company, engages in the discovery and development of oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Gimv
Gimv investment in Grant - Ablynx
Jefferies
Jefferies investment in Post-IPO Equity - Ablynx
KBC Securities
KBC Securities investment in Post-IPO Equity - Ablynx
Kempen & Co
Kempen & Co investment in Post-IPO Equity - Ablynx
KBC
KBC investment in Series C - Ablynx
Abingworth
Abingworth investment in Series C - Ablynx
Biotech Fund Flanders
Biotech Fund Flanders investment in Series C - Ablynx
Gilde Healthcare
Gilde Healthcare investment in Series C - Ablynx
Sofinnova Partners
Sofinnova Partners investment in Series C - Ablynx
Gimv
Gimv investment in Series C - Ablynx
Official Site Inspections
http://www.ablynx.com
- Host name: ec2-54-247-151-159.eu-west-1.compute.amazonaws.com
- IP address: 54.247.151.159
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
